Page 6 - 《中国药房》2021年12期

Meta-analysis of Non-immune Related Adverse Events Caused by ICIs Alone or Combined with Routine Che-
motherapy in the Treatment of Non-small Cell Lung Cancer ……………………………………………………
………………………… ZHANG Qingshu，CHEN Ruixiang，WEN Jin，XIA Conglong，HE Jiao，ZHAO Qian（1506）
Construction and Practice of Special Management System for Carbapenems in Our Hospital ……………………
…………………………………… SHEN Aizong，ZHANG Shengyu，CHEN Yongwu，SU Dan，SHAO Rong（1515）
Discussion on the Idea to Establish Standardized Construction Standard System for“Internet+TCM Pharmacy”
Based on Questionnaire Survey ………………………… XU Huifang，PENG Min，HUANG Qian，XU Yuting（1520）
Effects of Pharmaceutical Management Intervention on Clinical Use of TCM Injection in Primary Medical Insti-
tutions …………………………………… WANG Qun，JIN Zhao，HUANG Ying，HU Wen，LIU Bo，WU Ting（1526）

Postal Address
CHINA PHARMACY （Semimonthly） 129 Daping Main Street，Yuzhong District，Chongqing
Founded in January 1990 400042，China
Vol.32，No.12，Jun. 2021 Phone
Total No.702 Published on Jun. 30，2021
+86-23-63830521；+86-23-63830907；+86-23-68586727；
Responsible Institution +86-23-68586827
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Honorary Editor-in-Chief Overseas：China International Book Trading Corporation
MA Jin （Code No.4703SM）
Editor-in-Chief Subscription Rates
HU Xin CNY 15 per issue；CNY 360 per annum
Vice Editor-in-Chief CSSN ISSN 1001-0408
LENG Huaiming CN 50-1055/R
Chief Editor CODEN
ZHANG Jian ZYHAA4
Published by Perennial Legal Counsel
China Pharmacy Editorial Department Chongqing Huali Wantao Law Firm